Magnetar Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,425
| Closed | -$2.92M | – | 950 |
|
|
2025
Q3 | $2.92M | Buy |
+10,425
| New | +$2.84M | 0.02% | 310 |
|
|
2024
Q4 | – | Sell |
-3,283
| Closed | -$1.1M | – | 621 |
|
|
2024
Q3 | $1.1M | Buy |
+3,283
| New | +$1.04M | 0.02% | 278 |
|
|
2024
Q1 | – | Sell |
-4,336
| Closed | -$1.4M | – | 380 |
|
|
2023
Q4 | $1.4M | Buy |
4,336
+2,163
| +100% | +$678K | 0.04% | 232 |
|
|
2023
Q3 | $779K | Sell |
2,173
-734
| -25% | -$283K | 0.02% | 277 |
|
|
2023
Q2 | $1.1M | Buy |
+2,907
| New | +$1.18M | 0.02% | 264 |
|
|
2022
Q1 | – | Sell |
-1,220
| Closed | -$922K | – | 1338 |
|
|
2021
Q4 | $922K | Buy |
+1,220
| New | +$913K | 0.01% | 826 |
|
|
2021
Q2 | – | Sell |
-2,549
| Closed | -$1.46M | – | 1213 |
|
|
2021
Q1 | $1.46M | Buy |
+2,549
| New | +$1.51M | 0.01% | 622 |
|
|
2020
Q4 | – | Sell |
-414
| Closed | -$213K | – | 731 |
|
|
2020
Q3 | $213K | Sell |
414
-1,640
| -80% | -$831K | ﹤0.01% | 598 |
|
|
2020
Q2 | $927K | Buy |
+2,054
| New | +$906K | 0.03% | 195 |
|
|
2019
Q2 | – | Sell |
-737
| Closed | -$225K | – | 452 |
|
|
2019
Q1 | $225K | Sell |
737
-3,726
| -83% | -$1.01M | 0.01% | 363 |
|
|
2018
Q4 | $1.04M | Buy |
+4,463
| New | +$1.2M | 0.03% | 117 |
|
|
2018
Q1 | – | Sell |
-2,231
| Closed | -$532K | – | 590 |
|
|
2017
Q4 | $532K | Sell |
2,231
-3,568
| -62% | -$865K | 0.01% | 378 |
|
|
2017
Q3 | $1.29M | Buy |
5,799
+1,676
| +41% | +$377K | 0.02% | 224 |
|
|
2017
Q2 | $933K | Buy |
4,123
+1,941
| +89% | +$423K | 0.02% | 382 |
|
|
2017
Q1 | $435K | Buy |
+2,182
| New | +$420K | 0.01% | 499 |
|
|
2016
Q3 | – | Sell |
-2,752
| Closed | -$394K | – | 546 |
|
|
2016
Q2 | $394K | Buy |
2,752
+961
| +54% | +$137K | 0.01% | 261 |
|
|
2016
Q1 | $245K | Buy |
+1,791
| New | +$235K | ﹤0.01% | 336 |
|
|
2013
Q4 | – | Sell |
-4,842
| Closed | -$569K | – | 246 |
|
|
2013
Q3 | $569K | Buy |
+4,842
| New | +$571K | 0.02% | 376 |
|
Other funds holding BIO
AI
VAM